今日の臨床サポート 今日の臨床サポート

著者: 関川喜之 武蔵野赤十字病院 感染症科

監修: 上原由紀 藤田医科大学医学部感染症科

著者校正/監修レビュー済:2025/02/26
参考ガイドライン:
  1. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases 2014;59(2):147–59
  1. 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults, Clinical Infectious Diseases 2015;61(6):e26–46
  1. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis, Clinical Infectious Diseases 2016;63(7):e147–95
  1. 日本感染症学会/日本化学療法学会:JAID/JSC感染症治療ガイド2023
  1. 日本結核・非結核性抗酸菌症学会:結核診療ガイドライン2024
患者向け説明資料

改訂のポイント:
  1. 『結核診療ガイドライン2024』に従い、結核性脊椎炎の治療期間を6~9カ月間に変更した。
  1. 画像診断および膿瘍ドレナージに関するシステマティックレビューについて加筆した(Al-Khafaji MQ, et al. J Clin Med. 2024 May 29;13(11):3199.)。
  1. 片側性の腸腰筋膿瘍が多く、両側性はまれ(1~5%)と考えられていたが、最近では10%と報告がある。
  1. CTガイド下ドレナージの成功率は83.3%であるのに対して、超音波ガイド下ドレナージの成功率は33.3%と低い。
  1. 症例として、典型例と非典型例について画像を用いて解説した。

概要・推奨   

  1. 腸腰筋は大腰筋と腸骨筋、小腰筋から成り、同部位に膿瘍を形成する。
  1. 原発巣不明で血行性やリンパ管性に感染する原発性膿瘍(primary abscess)と隣接臓器より直達性に感染する続発性膿瘍(secondary abscess)に分類される。
  1. 起因微生物は Staphylococcus aureus が多い。
アカウントをお持ちの方はログイン
  1. 閲覧にはご契約が必要となります。閲覧にはご契約が必要となります。閲覧にはご契約が必要となります。閲覧には
  1. 閲覧にはご契約が必要となります。閲覧にはご契約が必要となります。閲覧にはご契約が必要とな
  1. 閲覧にはご契約が必要となります。閲覧にはご契
  1. 閲覧にはご契約が必要となります。閲覧にはご契約が必要となります
  1. 閲覧にはご契約が必要となります。閲覧に
  1. 閲覧にはご契約が必要となります。閲覧にはご契約が必要となります。閲覧にはご契
  1. 原発性膿瘍もしくは化膿性脊椎炎に続発する場合の経験的治療は Staphylococcus aureus を念頭にセファゾリンもしくはバンコマイシンを検討する。特に、数カ月以内の抗菌薬使用や長期入院、透析、HIV、過去のMRSA検出歴、CVカテーテルやFoleyカテーテルなどデバイス留置、違法静注薬物使用、コンタクトスポーツ(ラグビーやサッカーなど)がある場合はMRSAを想定しバンコマイシンを使用する(推奨度2)
  1. 腹腔内臓器に続発する場合の経験的治療は Staphylococcus aureus に加えて腸内細菌目細菌と偏性嫌気性菌をカバーし、バンコマイシン+アンピシリン・スルバクタム or ピペラシリン・タゾバクタム or カルバペネム or セフトリアキソン+メトロニダゾールを検討する(推奨度2)
  1. 閲覧にはご契約が必要となります。閲覧にはご契約が必要
  1. 閲覧にはご契約が必要となります。閲覧にはご契約が必要となります。閲覧にはご契約が必要となります。閲覧にはご契約が必要となります。閲覧にはご契約が必要となります。閲覧にはご契約が必要となります。閲覧にはご契約が必要となります。閲覧にはご契約が必要となります。閲覧にはご契約が必要となります

病態・疫学・診察 

定義  
  1. 腸腰筋とは、第12胸椎~第5腰椎から起こり大腿骨小転子に終わる大腰筋と、腸骨内面の腸骨窩から起こり大腿骨小転子に終わる腸骨筋、大腰筋前面にある小腰筋(半数では欠如)から成り、股関節を屈曲させる筋群(図<図表>)であり、腸腰筋膿瘍は同部位に膿瘍が形成される(図<図表>)。
 
腸腰筋の解剖学図

腸腰筋は、大腰筋、腸骨筋、小腰筋から成る。

出典

編集部作成
 
左腸腰筋膿瘍

左大腰筋に膿瘍を認める。

出典

Elaine C. Jong MD and Dennis L. Stevens PhD, MD:Netter's Infectious Diseases, Elsevier, 2012, Figure 51-2.
疫学  
  1. 本邦での頻度は不明。CTやMRIの発達により増加傾向と考えられる。英国の報告によれば、100万人あたり4例の頻度である[1]
  1. 原発性膿瘍の危険因子は、糖尿病、違法静注薬物使用者、HIV、腎不全、その他の免疫不全者が挙げられる[2]。小児、若年成人、熱帯地域の発展途上国に多い[3]
  1. 続発性膿瘍の危険因子は、後述する原疾患を持つ場合や鼠径部・腰椎・寛骨部の外傷や同部位の医療器具(インストゥルメント)の留置が挙げられる(表<図表>

これより先の閲覧には個人契約のトライアルまたはお申込みが必要です。

最新のエビデンスに基づいた二次文献データベース「今日の臨床サポート」。
常時アップデートされており、最新のエビデンスを各分野のエキスパートが豊富な図表や処方・検査例を交えて分かりやすく解説。日常臨床で遭遇するほぼ全ての症状・疾患から薬剤・検査情報まで瞬時に検索可能です。

まずは15日間無料トライアル
本サイトの知的財産権は全てエルゼビアまたはコンテンツのライセンサーに帰属します。私的利用及び別途規定されている場合を除き、本サイトの利用はいかなる許諾を与えるものでもありません。 本サイト、そのコンテンツ、製品およびサービスのご利用は、お客様ご自身の責任において行ってください。本サイトの利用に基づくいかなる損害についても、エルゼビアは一切の責任及び賠償義務を負いません。 また、本サイトの利用を以て、本サイト利用者は、本サイトの利用に基づき第三者に生じるいかなる損害についても、エルゼビアを免責することに合意したことになります。  本サイトを利用される医学・医療提供者は、独自の臨床的判断を行使するべきです。本サイト利用者の判断においてリスクを正当なものとして受け入れる用意がない限り、コンテンツにおいて提案されている検査または処置がなされるべきではありません。 医学の急速な進歩に鑑み、エルゼビアは、本サイト利用者が診断方法および投与量について、独自に検証を行うことを推奨いたします。

文献 

Bartolo DC, Ebbs SR, Cooper MJ.
Psoas abscess in Bristol: a 10-year review.
Int J Colorectal Dis. 1987 Jun;2(2):72-6. doi: 10.1007/BF01647695.
Abstract/Text A consecutive series of 16 cases of psoas abscess managed over a 10-year period at the Bristol Royal Infirmary is presented. Tuberculosis accounted for 4 patients all normally resident in the United Kingdom. Intraabdominal inflammatory disorders accounted for 9 of the cases with Crohn's disease being the commonest of these with 5 cases. The remaining patients comprised 3 with primary staphylococcal abscesses, one appendicitis, one diverticulitis and 2 with colonic carcinoma. Diagnostic delay was common. Ultrasonography together with guided aspiration of pus was the most useful investigation giving the diagnosis in cases due to tuberculosis and staphylococci. The presence of gut associated organisms was indicative of gastrointestinal pathology. Four patients died and significant morbidity occurred in a further 5. We recommend effective dependent drainage together with resection of diseased gut in the cases of gastrointestinal origin.

PMID 3625011
Mückley T, Schütz T, Kirschner M, Potulski M, Hofmann G, Bühren V.
Psoas abscess: the spine as a primary source of infection.
Spine (Phila Pa 1976). 2003 Mar 15;28(6):E106-13. doi: 10.1097/01.BRS.0000050402.11769.09.
Abstract/Text STUDY DESIGN: Case report, literature review, discussion.
OBJECTIVES: To emphasize the role of the spine as primary source of infection for psoas abscess.
SUMMARY OF BACKGROUND DATA: Spine-associated psoas abscesses increase with more frequent invasive procedures of the spine and recurring tuberculosis in industrialized countries. Diagnosis is often delayed by misinterpretation as arthritis, joint infection, or urologic or abdominal disorders.
METHODS: We present six cases of psoas abscesses associated with spinal infections that were treated in our hospital from January to December 2001. Diagnostic and treatment concepts are discussed.
RESULTS: Our data emphasize the importance of the spine as primary source of infection and suggest an increase in the incidence of secondary psoas abscess. Treatment includes open surgical drainage and antibiotic therapy. In patients with high operative risk and uniloculated abscess, a CT-guided percutaneous abscess drainage can be sufficient. It is essential to combine abscess drainage with causative treatment of the primary infectious focus. Related to the spine, this includes treatment of spondylodiscitis or implant infection after spinal surgery. Usually, several operations are necessary to eradicate bone and soft-tissue infection and restore spinal stability. Continuous antibiotic therapy over a period of 2-3 weeks after normalization of infectious parameters is recommended.
CONCLUSION: The spine as primary source of infection for secondary psoas abscess should always be included in differential diagnosis. Because the prognosis of psoas abscess can be improved by early diagnosis and prompt onset of therapy, it needs to be considered in patients with infection and back or hip pain or history of spinal surgery.

PMID 12642773
Ricci MA, Rose FB, Meyer KK.
Pyogenic psoas abscess: worldwide variations in etiology.
World J Surg. 1986 Oct;10(5):834-43. doi: 10.1007/BF01655254.
Abstract/Text
PMID 3776220
López VN, Ramos JM, Meseguer V, Pérez Arellano JL, Serrano R, Ordóñez MAG, Peralta G, Boix V, Pardo J, Conde A, Salgado F, Gutiérrez F; GTI-SEMI Group.
Microbiology and outcome of iliopsoas abscess in 124 patients.
Medicine (Baltimore). 2009 Mar;88(2):120-130. doi: 10.1097/MD.0b013e31819d2748.
Abstract/Text To describe the microbiology and outcome of iliopsoas abscess (IPA) in a large case series, we analyzed 124 cases of IPA collected from 1990 through 2004 in 11 hospitals in Spain. Twenty-seven (21.8%) patients had primary and 97 (78.2%) had secondary IPA. The main sources of infection were bone (50.5%), gastrointestinal tract (24.7%), and urinary tract (17.5%). A definitive microbial diagnosis was achieved in 93 (75%) cases. Abscess culture was the most frequent procedure leading to microbial diagnosis, followed by blood cultures. Staphylococcus aureus, Escherichia coli, and Bacteroides species were the most frequent microbial causes: S. aureus was the most common organism in patients with primary abscesses (42.9%) and with abscesses of skeletal origin (35.2%), whereas E. coli was the leading organism in those with abscesses of urinary (61.5%) and gastrointestinal (42.1%) tracts. Mycobacterium tuberculosis was found in 15 patients, 4 of them associated with human immunodeficiency virus (HIV) infection. Twenty (21.5%) cases had polymicrobial infections; these were more common among patients with abscesses of gastrointestinal origin. Information on clinical outcome was available for 120 patients; 19 (15.8%) had a relapse and 6 (5%) died due to complications related to the IPA. Patients who died were older and more likely to have bacteremia and E. coli isolated from cultures. In conclusion, secondary IPA is more prevalent than primary IPA. Among those with secondary IPA, most abscesses are secondary to a skeletal source. A bacterial etiology can be identified in most cases. The overall prognosis of patients with this condition is good.

PMID 19282703
Ogihara M, Masaki T, Watanabe T, Hatano K, Matsuda K, Yahagi N, Ichinose M, Seichi A, Muto T.
Psoas abscess complicating Crohn's disease: report of a case.
Surg Today. 2000;30(8):759-63. doi: 10.1007/s005950070093.
Abstract/Text We describe herein the case of a psoas abscess complicating Crohn's disease, and present a review of the literature on this unusual disease entity. A 22-year-old Japanese man with a 5-year history of Crohn's ileocolitis presented with right lower abdominal and hip pain, and a diagnosis of right psoas abscess was subsequently made by abdominal computed tomography (CT). Following the administration of antibiotics and CT-guided percutaneous drainage of the abscess, the patient's symptoms temporarily improved; however, 2 weeks later, the abscess cavity was found to have extended around the periarticular tissue of the right hip joint. To prevent the development of septic arthritis of the hip joint, surgical drainage of the abscess cavity and ileocecal resection were immediately performed, after which the patient's condition greatly improved. The resected specimen showed Crohn's ileocolitis with an external fistula in the terminal ileum which was considered to have caused the psoas abscess. Since psoas abscess in Crohn's disease can result in serious complications such as septic arthritis of the hip joint if left untreated, aggressive treatment should be initiated without delay.

PMID 10955745
Hsu RB, Lin FY.
Psoas abscess in patients with an infected aortic aneurysm.
J Vasc Surg. 2007 Aug;46(2):230-5. doi: 10.1016/j.jvs.2007.04.017. Epub 2007 Jun 27.
Abstract/Text BACKGROUND: Psoas abscess is an uncommon disease, and its presenting features are usually nonspecific. Infected aortic aneurysms could be complicated by psoas abscess.
METHODS: A retrospective chart review was conducted to examine the incidence, clinical presentations, microbiology, and outcomes of psoas abscess in patients with an infected aortic aneurysm.
RESULTS: Between 1996 and 2007, 40 patients (32 men) with an infected infrarenal aortic aneurysm were treated in our hospital. Their median age was 71 years (range, 38 to 88 years). In 38 patients a blood or tissue culture had a positive result. The most common responsible pathogen was Salmonella spp in 29 patients (76%), followed by Staphylococcus aureus in 3 (8%), Escherichia coli in 2 (5%), Klebsiella pneumoniae in 3 (8%), and Mycobacterium tuberculosis in 1 (3%). One patient underwent endovascular repair but died. In-situ graft replacement was done in 32 patients. Persistent or recurrent infection occurred in seven (22%) of 32 operated on patients. The mortality rate was 86%, and the overall aneurysm-related mortality rate of in situ graft replacement was 22% (7/32). In eight (20%) of the 40 patients, aortic infection was complicated by psoas abscess. Infection complicated by psoas abscess was present in seven of 32 operated patients. It was associated with higher incidence of emergency operation, hospital mortality, prosthetic graft infection, and aneurysm-related mortality than infection without abscess.
CONCLUSION: Psoas abscess was common in patients with infected infrarenal aortic aneurysm. Salmonella spp was the most common pathogen. Psoas abscess was associated with a high mortality rate, emergency operation, and persistent infection.

PMID 17600660
Mallick IH, Thoufeeq MH, Rajendran TP.
Iliopsoas abscesses.
Postgrad Med J. 2004 Aug;80(946):459-62. doi: 10.1136/pgmj.2003.017665.
Abstract/Text Iliopsoas abscess is a relatively uncommon condition that can present with vague clinical features. Its insidious onset and occult characteristics can cause diagnostic delays, resulting in high mortality and morbidity. The epidemiology, aetiology, clinical features, and management of iliopsoas abscess are discussed.

PMID 15299155
Al-Khafaji MQ, Al-Smadi MW, Al-Khafaji MQ, Aslan S, Al-Khafaji YQ, Bagossy-Blás P, Al Nasser MH, Horváth BL, Viola Á.
Evaluating Imaging Techniques for Diagnosing and Drainage Guidance of Psoas Muscle Abscess: A Systematic Review.
J Clin Med. 2024 May 29;13(11). doi: 10.3390/jcm13113199. Epub 2024 May 29.
Abstract/Text Background: Psoas muscle abscess (PMA) is an uncommon yet severe condition characterized by diagnostic and therapeutic challenges due to its varied etiology and nonspecific symptoms. This study aimed to evaluate the effectiveness and accuracy of various imaging techniques used in the image-guided percutaneous drainage (PD) of PMA. Methods: A systematic review was conducted following the PRISMA guidelines. We searched PubMed, Google Scholar, and Science Direct for studies published in English from 1998 onwards that reported on the use of PD in treating PMA, detailing outcomes and complications. Imaging modalities guiding PD were also examined. Results: We identified 1570 articles, selecting 39 for full review. Of these, 23 met the inclusion criteria; 19 were excluded due to unspecified PMA, absence of imaging guidance for PD, or inconclusive results. Eleven studies utilized computed tomography (CT) for PD, with six also using magnetic resonance imaging (MRI). Ten studies implemented ultrasound (US)-guided PD; variations in diagnostic imaging included combinations of US, CT, and MRI. A mixed approach using both CT and US was reported in two articles. Most studies using CT-guided PD showed complete success, while outcomes varied among those using US-guided PD. No studies employed MRI-guided PD. Conclusions: This review supports a multimodal approach for psoas abscess management, using MRI for diagnosis and CT for drainage guidance. We advocate for Cone Beam CT (CBCT)-MRI fusion techniques with navigation systems to enhance treatment precision and outcomes, particularly in complex cases with challenging abscess characteristics.

PMID 38892910
Lin MF, Lau YJ, Hu BS, Shi ZY, Lin YH.
Pyogenic psoas abscess: analysis of 27 cases.
J Microbiol Immunol Infect. 1999 Dec;32(4):261-8.
Abstract/Text From 1993 to 1998, 29 pyogenic psoas abscesses occurring in 27 patients were seen in Taichung Veterans General Hospital. Their age range was 25 to 85 years. Diabetes mellitus was the leading underlying disease. Fever and pain in the flank area, back and hip were the usual manifestations. The duration of symptoms prior to the diagnosis ranged from 3 days to 6 months. Most abscesses were diagnosed by computed tomography (CT) images and proven by abscess cultures, which were divided into primary and secondary types. Eighteen of 29 abscesses were regarded as primary. Staphylococcus aureus was the most common pathogen in the primary abscesses, followed by Streptococcus agalactiae, Escherichia coli, viridans streptococci, S. epidermidis, and Salmonella spp.. In the secondary abscess category, E. coli was the leading organism in this series, followed by S. aureus, Klebsiella pneumoniae, viridans streptococci and Candida albicans. The associated conditions included epidural abscess, osteomyelitis, septic arthritis, perirenal abscess, pulmonary tuberculosis, empyema, hydronephrosis and trauma history. The initial empiric therapy comprised mostly of cefazolin or oxacillin with or without an aminoglycoside. Thirteen patients underwent percutaneous drainage, while six received surgical debridement, including two with a recurrent abscess. One patient had both drainage and debridement. Others received medical treatment only. Two of the patients with primary abscess died in spite of percutaneous drainage. Therefore, open drainage, besides appropriate antibiotic treatment, is still required to control complex abscesses with sepsis.

PMID 10650491
Takada T, Terada K, Kajiwara H, Ohira Y.
Limitations of using imaging diagnosis for psoas abscess in its early stage.
Intern Med. 2015;54(20):2589-93. doi: 10.2169/internalmedicine.54.4927. Epub 2015 Oct 15.
Abstract/Text Objective Patients diagnosed with psoas abscess have a high mortality rate. The major cause of its poor prognosis is delayed treatment. Therefore, making a correct diagnosis rapidly is important. Both computed tomography (CT) and magnetic resonance imaging (MRI) are considered to be the gold standards as imaging modalities that have a high sensitivity for detecting psoas abscess. There have been few reports regarding the limitations of these methods, but psoas abscess in its early stage may go undetected by CT and MRI. Methods Detection of psoas abscess by CT and MRI was investigated in the present study through a retrospective review of 15 patients in whom psoas abscess was diagnosed during a course of ten years at our hospital. Results In all patients, psoas abscess was diagnosed by at least a plain CT, enhanced CT, and/or plain MRI. The interval between the onset of symptoms and diagnosis was 20.9±17.9 days (mean ± standard deviation). In three patients, repeat imaging identified a psoas abscess, whereas initial imaging failed to detect it. The overall sensitivity of plain CT, enhanced CT, and plain MRI for psoas abscess was 78%, 86%, and 88%, respectively. From six days after the onset of symptoms, the sensitivity of each modality was 100%, while the sensitivity from day one to five days was only 33%, 50%, and 50%, respectively. Conclusion Although CT and MRI are considered to be gold standard modalities for diagnosing psoas abscess, both methods can fail to notice this condition in its early stage.

PMID 26466693
Pigrau C, Almirante B, Flores X, Falco V, Rodríguez D, Gasser I, Villanueva C, Pahissa A.
Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome.
Am J Med. 2005 Nov;118(11):1287. doi: 10.1016/j.amjmed.2005.02.027.
Abstract/Text PURPOSE: The relationship between pyogenic vertebral osteomyelitis and infectious endocarditis is uncertain. This study investigates the incidence and risk factors of infectious endocarditis in patients with pyogenic vertebral osteomyelitis, and the outcome of pyogenic vertebral osteomyelitis with and without associated infectious endocarditis.
METHODS: A retrospective record review was conducted of all cases of vertebral osteomyelitis from January 1986 to June 2002, occurring in a tertiary referral hospital. Patients were followed for at least 6 months with careful attention to detection of infectious endocarditis and relapses.
RESULTS: Among 606 patients with infectious endocarditis, 28 (4.6%) had pyogenic vertebral osteomyelitis. Among 91 cases of pyogenic vertebral osteomyelitis, 28 (30.8%) had infectious endocarditis. In 6 patients with no clinical signs of infectious endocarditis, the disease was established by routine echocardiography. Infectious endocarditis was more common in patients with predisposing heart conditions and streptococcal pyogenic vertebral osteomyelitis infection. Overall, pyogenic vertebral osteomyelitis in-hospital mortality was 11% (7.1% with infectious endocarditis). Twelve of 25 patients with infectious endocarditis with uncomplicated pyogenic vertebral osteomyelitis were treated for 4 to 6 weeks (endocarditis protocol), with no pyogenic vertebral osteomyelitis relapses.
CONCLUSIONS: When specifically sought, the incidence of infectious endocarditis is high in patients with pyogenic vertebral osteomyelitis. Oral therapy may be an option for uncomplicated pyogenic vertebral osteomyelitis; nevertheless, in gram-positive infections, this approach should only be considered after excluding infectious endocarditis. Favorable outcome with shorter treatment in uncomplicated pyogenic vertebral osteomyelitis associated with infectious endocarditis suggests that prolonged therapy may not be needed in this subgroup except for those infected by difficult to treat microorganisms, such as methicillin-resistant Staphylococcus aureus or Candida spp.

PMID 16271915
Dave BR, Kurupati RB, Shah D, Degulamadi D, Borgohain N, Krishnan A.
Outcome of percutaneous continuous drainage of psoas abscess: A clinically guided technique.
Indian J Orthop. 2014 Jan;48(1):67-73. doi: 10.4103/0019-5413.125506.
Abstract/Text BACKGROUND: Percutaneous aspiration of abscesses under ultrasonography (USG) and computer tomography (CT) scan has been well described. With recurrence rate reported as high as 66%. The open drainage and percutaneous continuous drainage (PCD) has reduced the recurrence rate. The disadvantage of PCD under CT is radiation hazard and problems of asepsis. Hence a technique of clinically guided percutaneous continuous drainage of the psoas abscess without real-time imaging overcomes these problems. We describe clinically guided PCD of psoas abscess and its outcome.
MATERIALS AND METHODS: Twenty-nine patients with dorsolumbar spondylodiscitis without gross neural deficit with psoas abscess of size >5 cm were selected for PCD. It was done as a day care procedure under local anesthesia. Sequentially, aspiration followed by guide pin-guided trocar and catheter insertion was done without image guidance. Culture sensitivity was done and chemotherapy initiated and catheter kept till the drainage was <10 ml for 48 hours. Outcome assessment was done with relief of pain, successful abscess drainage and ODI (Oswestry Disability Index) score at 2 years.
RESULTS: PCD was successful in all cases. Back and radicular pain improved in all cases. Average procedure time was 24.30 minutes, drain output was 234.40 ml, and the drainage duration was 7.90 days. One patient required surgical stabilisation due to progression of the spondylodiscitis resulting in instability inspite of successful drainage of abscess. Problems with the procedure were noticed in six patients. Multiple attempts (n = 2), persistent discharge (n = 1) for 2 weeks, blocked catheter (n = 2) and catheter pull out (n = 1) occurred with no effect on the outcome. The average ODI score improved from 62.47 to 5.51 at 2 years.
CONCLUSIONS: Clinically guided PCD is an efficient, safe and easy procedure in drainage of psoas abscess.

PMID 24600066
Yacoub WN, Sohn HJ, Chan S, Petrosyan M, Vermaire HM, Kelso RL, Towfigh S, Mason RJ.
Psoas abscess rarely requires surgical intervention.
Am J Surg. 2008 Aug;196(2):223-7. doi: 10.1016/j.amjsurg.2007.07.032. Epub 2008 May 7.
Abstract/Text BACKGROUND: Surgeons are increasingly encountering psoas abscesses.
METHODS: We performed a review of 41 adults diagnosed and treated for psoas abscess at a county hospital. Treatment modalities and outcomes were evaluated to develop a contemporary algorithm.
RESULTS: Eighteen patients had a primary psoas abscess, and 23 had a secondary psoas abscess. Patient characteristics were similar in both groups. Intravenous drug abuse was the leading cause of primary abscesses. Secondary abscesses developed most commonly after abdominal surgery. Treatment was via open drainage (3%), computed tomography-guided percutaneous drainage (63%), or antibiotics alone (34%). Four recurrences occurred in the percutaneous group. Statistical analysis showed that the median size of psoas abscesses in the percutaneous group was significantly larger than in the antibiotics group (6 vs 2 cm; P < .001). The mortality rate was 3%.
CONCLUSIONS: Initial management of psoas abscesses should be nonsurgical (90% success). Small abscesses may be treated with antibiotics alone, and surgery can be reserved for occasional complicated recurrences.

PMID 18466865
薬剤監修について:
オーダー内の薬剤用量は日本医科大学付属病院 薬剤部 部長 伊勢雄也 以下、渡邉裕次、井ノ口岳洋、梅田将光および日本医科大学多摩永山病院 副薬剤部長 林太祐による疑義照会のプロセスを実施、疑義照会の対象については著者の方による再確認を実施しております。
※薬剤中分類、用法、同効薬、診療報酬は、エルゼビアが独自に作成した薬剤情報であり、 著者により作成された情報ではありません。
尚、用法は添付文書より、同効薬は、薬剤師監修のもとで作成しております。
※同効薬・小児・妊娠および授乳中の注意事項等は、海外の情報も掲載しており、日本の医療事情に適応しない場合があります。
※薬剤情報の(適外/適内/⽤量内/⽤量外/㊜)等の表記は、エルゼビアジャパン編集部によって記載日時にレセプトチェックソフトなどで確認し作成しております。ただし、これらの記載は、実際の保険適応の査定において保険適応及び保険適応外と判断されることを保証するものではありません。また、検査薬、輸液、血液製剤、全身麻酔薬、抗癌剤等の薬剤は保険適応の記載の一部を割愛させていただいています。
(詳細はこちらを参照)
著者のCOI(Conflicts of Interest)開示:
関川喜之 : 特に申告事項無し[2024年]
監修:上原由紀 : 研究費・助成金など(花王(株))[2024年]

ページ上部に戻る

腸腰筋膿瘍

戻る